Mallett, Andrew
Kearey, Phoebe Jane
Cameron, Anne
Healy, Helen G.
Denaro, Charles
Thomas, Mark
Lee, Vincent W.
Stark, Samantha Louise
Fuller, Maria
Wang, Zaimin
Hoy, Wendy E.
Article History
Received: 27 February 2022
Accepted: 27 April 2022
First Online: 4 May 2022
Declarations
:
: The aCQuiRE Study received multi-site ethical approval from the Royal Brisbane and Women’s Hospital Human Research Ethics Committee (Approval number: HREC/17/QRBW/91) and subsequent governance approval at all study sites. Governance and ethical processes included approval of this protocol. All patients provide informed, written consent prior to participation in the study. All methods were carred out in accordance with relevant guidelines and regulations.
: Not applicable.
: MT has previously received fees for lectures, advisory boards and conference attendance from Sanofi-Genzyme. CD is a member of the Sanofi Genzyme Educational Advisory Board and has previously received sponsorship to attend conferences. SS has received fees from Sanofi-Genzyme for Advisory Board participation. AM is a member of the BMC Nephrology Editorial Board (Associate Editor) and has had no role in the peer review or handling of the protocol manuscript by that journal. The other authors declare that they have no competing interests.